Perspective on the Use of Sulfated Polysaccharides from Marine Organisms as a Source of New Antithrombotic Drugs

Thromboembolic diseases are increasing worldwide and always require anticoagulant therapy. We still need safer and more secure antithrombotic drugs than those presently available. Sulfated polysaccharides from marine organisms may constitute a new source for the development of such drugs. Investigat...

Full description

Bibliographic Details
Main Author: Paulo A. S. Mourão
Format: Article
Language:English
Published: MDPI AG 2015-05-01
Series:Marine Drugs
Subjects:
Online Access:http://www.mdpi.com/1660-3397/13/5/2770
_version_ 1818013518528512000
author Paulo A. S. Mourão
author_facet Paulo A. S. Mourão
author_sort Paulo A. S. Mourão
collection DOAJ
description Thromboembolic diseases are increasing worldwide and always require anticoagulant therapy. We still need safer and more secure antithrombotic drugs than those presently available. Sulfated polysaccharides from marine organisms may constitute a new source for the development of such drugs. Investigation of these compounds usually attempts to reproduce the therapeutic effects of heparin. However, we may need to follow different routes, focusing particularly in the following aspects: (1) defining precisely the specific structures required for interaction of these sulfated polysaccharides with proteins of the coagulation system; (2) looking for alternative mechanisms of action, distinct from those of heparin; (3) identifying side effects (mostly pro-coagulant action and hypotension rather than bleeding) and preparing derivatives that retain the desired antithrombotic action but are devoid of side effects; (4) considering that sulfated polysaccharides with low anticoagulant action on in vitro assays may display potent effects on animal models of experimental thrombosis; and finally (5) investigating the antithrombotic effect of these sulfated polysaccharides after oral administration or preparing derivatives that may achieve this effect. If these aspects are successfully addressed, sulfated polysaccharides from marine organisms may conquer the frontier of antithrombotic therapy and open new avenues for treatment or prevention of thromboembolic diseases.
first_indexed 2024-04-14T06:34:12Z
format Article
id doaj.art-00f1342cfb4942efa5e35614ef41fb6d
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-04-14T06:34:12Z
publishDate 2015-05-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-00f1342cfb4942efa5e35614ef41fb6d2022-12-22T02:07:31ZengMDPI AGMarine Drugs1660-33972015-05-011352770278410.3390/md13052770md13052770Perspective on the Use of Sulfated Polysaccharides from Marine Organisms as a Source of New Antithrombotic DrugsPaulo A. S. Mourão0Connective Tissue Research Laboratory, University Hospital Clementino Fraga Filho, Rio de Janeiro, RJ 21941-590, BrazilThromboembolic diseases are increasing worldwide and always require anticoagulant therapy. We still need safer and more secure antithrombotic drugs than those presently available. Sulfated polysaccharides from marine organisms may constitute a new source for the development of such drugs. Investigation of these compounds usually attempts to reproduce the therapeutic effects of heparin. However, we may need to follow different routes, focusing particularly in the following aspects: (1) defining precisely the specific structures required for interaction of these sulfated polysaccharides with proteins of the coagulation system; (2) looking for alternative mechanisms of action, distinct from those of heparin; (3) identifying side effects (mostly pro-coagulant action and hypotension rather than bleeding) and preparing derivatives that retain the desired antithrombotic action but are devoid of side effects; (4) considering that sulfated polysaccharides with low anticoagulant action on in vitro assays may display potent effects on animal models of experimental thrombosis; and finally (5) investigating the antithrombotic effect of these sulfated polysaccharides after oral administration or preparing derivatives that may achieve this effect. If these aspects are successfully addressed, sulfated polysaccharides from marine organisms may conquer the frontier of antithrombotic therapy and open new avenues for treatment or prevention of thromboembolic diseases.http://www.mdpi.com/1660-3397/13/5/2770sulfated fucanssulfated galactansanticoagulant drugsglycosaminoglycan-like polysaccharidesfucosylated chondroitin sulfatefucoidancarrageenans
spellingShingle Paulo A. S. Mourão
Perspective on the Use of Sulfated Polysaccharides from Marine Organisms as a Source of New Antithrombotic Drugs
Marine Drugs
sulfated fucans
sulfated galactans
anticoagulant drugs
glycosaminoglycan-like polysaccharides
fucosylated chondroitin sulfate
fucoidan
carrageenans
title Perspective on the Use of Sulfated Polysaccharides from Marine Organisms as a Source of New Antithrombotic Drugs
title_full Perspective on the Use of Sulfated Polysaccharides from Marine Organisms as a Source of New Antithrombotic Drugs
title_fullStr Perspective on the Use of Sulfated Polysaccharides from Marine Organisms as a Source of New Antithrombotic Drugs
title_full_unstemmed Perspective on the Use of Sulfated Polysaccharides from Marine Organisms as a Source of New Antithrombotic Drugs
title_short Perspective on the Use of Sulfated Polysaccharides from Marine Organisms as a Source of New Antithrombotic Drugs
title_sort perspective on the use of sulfated polysaccharides from marine organisms as a source of new antithrombotic drugs
topic sulfated fucans
sulfated galactans
anticoagulant drugs
glycosaminoglycan-like polysaccharides
fucosylated chondroitin sulfate
fucoidan
carrageenans
url http://www.mdpi.com/1660-3397/13/5/2770
work_keys_str_mv AT pauloasmourao perspectiveontheuseofsulfatedpolysaccharidesfrommarineorganismsasasourceofnewantithromboticdrugs